Introduction
============

The ADAMs (a disintegrin and metalloproteinase) and the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin-like motifs) are members of the M12 adamalysin family of the metzincin metalloproteinases, related to the matrix metalloproteinases (MMPs) \[[@r1],[@r2]\]. They are highly influential, multifunctional enzymes that regulate the extracellular microenvironment as well as cell signaling. In particular, the ADAMs have adhesive properties via their disintegrin and Cys-rich domains, while those that are active proteases mediate diverse protein ectodomain shedding events that liberate and regulate biologically active molecules at the cell surface \[[@r1],[@r2]\]. The ADAMTS family members have roles in the processing of procollagen molecules and cleavage of matrix hyalectans such as aggrecan, brevican and versican, while ADAMTS-13 is involved in hemostasis as the von Willebrand factor-cleaving proteinase \[[@r3]\]. Several ADAM/ADAMTS enzymes have roles in cell differentiation and cell guidance mechanisms during development \[[@r2],[@r3]\]. The ADAM/ADAMTSs are thus likely to be relevant to the function of the normal lens and alterations in their expression may be significant in lens pathologies, such as posterior capsule opacification (PCO) \[[@r4]\].

Up to 34 ADAM orthologs have now been discovered in many species from vertebrates to *Caenorhabditis elegans*, including 19 human ADAMs \[[@r5]\]. ADAM structure comprises a prodomain and a metalloproteinase domain followed by a disintegrin domain that has the ability to associate with integrins \[[@r2]\]. Linked to this are cysteine-rich and EGF-like domains that attach to a transmembrane domain and cytoplasmic tail \[[@r6],[@r7]\]. The ADAMTS are structurally distinguished by the inclusion of often multiple thrombospondin-like motifs, the lack of the transmembrane domain which gives them extracellular functions, and also the lack of the EGF-like domain. Since the discovery of the first ADAMTS in 1997, 19 human ADAMTS family members have been described \[[@r8],[@r9]\].

There is limited published research on the role of ADAM/ADAMTS families in the eye. In the developing chick cornea ADAM-10 has been linked with cell migration \[[@r10]\] and in the human cornea ADAMTS-1 interacts with fibulin proteins, which are ECM components that regulate organ shape \[[@r11]\]. Additionally, a study conducted during chick embryogenesis localized ADAM-35 (meltrin ε) to epithelial tissues derived from the surface ectoderm, including the lens placode and subsequently to the lens vesicles \[[@r12]\].

There are a small number of references that link the ADAM/ADAMTS with abnormal eye pathology. With respect to the lens; decreased ADAM-9 expression was detected in human anterior polar cataractous lenses (also referred to as anterior subcapsular cataract; ASC) relative to clear controls and ADAM-9 expression could be differentially regulated in BALB/c wild type mouse lens epithelial explants by culturing with TGFβ \[[@r13]\]. Additionally, lenticular abnormality in the connective tissue disorder Weill-Marchesani syndrome has been linked with *ADAMTS-10* gene mutation \[[@r14]\]. Using a proteomic approach, ADAM-19, −21, and ADAMTS-8 were detected in the anterior lens capsules of patients with co-existing Exfoliation syndrome (XFS) \[[@r15]\]. XFS is a major cause of glaucoma in which abnormal matrix deposits occur in the anterior segment (often in close relation to the lens) and is associated with cataract \[[@r16]\].

Limited information is available regarding gene expression in individual human lenses and therefore members of the *ADAM*/*ADAMTS* gene families were selected for study in the native lens, the wound healing lens and the post-cataractous lens capsular bag (ex vivo). The genes selected encode catalytically active ADAMs with a membrane-anchored metalloproteinase domain containing a catalytic-site consensus sequence \[[@r2]\]. The selected *ADAMTS* genes encode secreted ADAMTS proteins that were identified for their enzyme substrate specificities and had likely relevance to the lens. The candidate genes were *ADAM-8*, *-9*, *-10*, *-12*, *-15*, *-17*, −19, and *-28*, and the *ADAMTS* were *ADAMTS-1*, *-2*, *-3*, and *-14*.

The emphasis for this study was to report the gene expression of selected *ADAM*/*ADAMTS* in individual human lenses and so we used techniques that had been previously developed \[[@r17]\]. *ADAM*/*ADAMTS* gene expression patterns were analyzed in different regions of the same lens that had undergone; (1) sham cataract surgery in vitro to mimic the in vivo reality of a cataract operation (t=0), (2) in capsular bags following sham surgery in vitro that were cultured in unsupplemented medium for six days (t=6d) and in (3) capsular bags ex vivo that had previously undergone cataract surgery before death. The information gained provides insights into the potential roles of *ADAM*s/*ADAMTS*s in both the intact normal human lens and during wound healing responses following surgery.

Methods
=======

Donor lens selection and short-term lens culture
------------------------------------------------

Human donor eyes were obtained with full ethical permission from the East Anglian Eye Bank (EAEB) or the Corneal Transplant Service (Eye Bank, Bristol) after corneo-scleral discs had been removed for transplantation purposes. The use of human tissue in the study was in accordance with the provisions of the Declaration of Helsinki. All eyes were stored in individual sterile pots in an antibiotic wash medium before use. Regional dissection for gene expression analysis \[[@r17]\] and capsular bag culture methods \[[@r18]\] have been published previously.

The following human donor eyes were obtained postmortem for gene expression analyses: native (t=0) n=3, age range 74--84 years, mean=79.3 years; for culture (t=6d): n=3, age range 69--76, mean=73.7; and for analyses of capsular bags from donors who had previously undergone cataract surgery (ex vivo): n=3, age range 70--76, mean=73.6. In the latter case the time between surgery and death was not known, however there was evidence of PCO in all cases; notably cells had encroached upon the central posterior capsule and exhibited fibrotic changes such as matrix wrinkling and cell aggregation. Native lenses were dissected into three regions; anterior epithelia, equatorial region and fibers using published methodology \[[@r17]\], as mentioned. Briefly, the iris was removed and a circular anterior epithelium (capsulorhexis) torn away. The lens nucleus was then released by hydroejection and residual fibers were carefully sampled using forceps. Finally the lens capsule was dissected from the zonules.

Capsular bags for short-term culture were secured on to a sterile PMMA culture dish using six to eight entomological pins (D1; Watkins and Doncaster Ltd., Kent, UK), inserted through the edge of the capsular bag to maintain its shape and were then cultured for six days in unsupplemented Eagle minimal essential medium (EMEM; Sigma, Dorset, UK). The capsular bags from donors who had undergone cataract surgery and intra-ocular lens (IOL) implantation before death were dissected free from the globe as described and the IOL was removed. Immediately following preparation each sample was snap-frozen in liquid nitrogen.

Total RNA extraction and cDNA generation
----------------------------------------

Total RNA was extracted from lens tissue and cultured capsular bag samples according to the manufacturers of the RNeasy micro kits (Qiagen, West Sussex, UK). In the initial step RLT buffer (containing β-mercaptoethanol) was added to Eppendorf tubes containing snap frozen samples. The samples were then homogenized using an Eppendorf homogenizer and were then passed through a 20 gauge needle (0.9 mm) and syringe. The remainder of the protocol was as described by the manufacturer and included a DNase step. Quality control was performed to ensure that 28S and 18S rRNA bands were clearly evident in total RNA samples using an Agilent Bioanalyzer 2100 (Agilent, West Lothain, UK) and a RNA 6000 Nano labchip. RNA was quantified using a NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE). For the total of 15 samples analyzed, the ratio of adsorptions at 260/280 nm ranged from 1.8 to 2.2 (mean=2.0). Where possible, total RNA was immediately used for cDNA generation or briefly stored over night at −80 °C. Generation of cDNA was performed with Superscript II reverse transcriptase (Invitrogen, Paisley, UK) according to the reverse transcription (RT) protocols of the manufacturer using random primers (Promega, Southampton, UK).

Real time PCR
-------------

Real time PCR was used to quantitate mRNA for all genes expressed by native tissue, cultured and ex vivo capsular bags, relative to endogenous control genes. Oligonucleotide primers and fluorescence-labeled probes for *ADAM*/*ADAMTS* genes were designed in house using Primer Express 1.0 software (Applied Biosystems, Foster City, CA). The sequences are presented in [Table 1](#t1){ref-type="table"}. A pre-designed TaqMan® Gene expression assay was purchased (Applied Biosystems) for eukaryotic 18S rRNA expression quantitation (NCBI Reference Sequence \[RefSeq\] at the time of publication; [X03205.1](http://www.ncbi.nlm.nih.gov/nuccore/36162) and primer probe set ID; Hs99999901_s1) and used according to the manufacturer's instructions.

###### Taqman primer/probe sets for *ADAM* and *ADAMTS* family members.

  **Gene**   **Reference**   **Forward primer (5'-3')**     **Reverse primer (3' -- 5')**   **Probe (5'-FAM -- TAMRA-3')**          **NCBI accession number**
  ---------- --------------- ------------------------------ ------------------------------- --------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ADAM 8     \[[@r20]\]      AAGCAGCCGTGCGTCATC             AACCTGTCCTGACTATTCCAAATCTC      AATCACGTGGACAAGCTATATCAGAAACTCAACTTCC   [NM_001109](http://www.ncbi.nlm.nih.gov/nuccore/256773263)
  ADAM9      \-              GGAAACTGCCTTCTTAATATTCCAAA     CCCAGCGTCCACCAACTTAT            CCTGATGAAGCCTATAGTGCTCCCTCCTGT          [NM_003816.2](http://www.ncbi.nlm.nih.gov/nuccore/54292119) , [NM_001005845.1](http://www.ncbi.nlm.nih.gov/nuccore/NM_001005845.1?report=genbank)
  ADAM10     \[[@r19]\]      AGCGGCCCCGAGAGAGT              AGGAAGAACCAAGGCAAAAGC           ATCAAATGGGACACATGAGACGCTAACTGC          [NM_001110](http://www.ncbi.nlm.nih.gov/nuccore/73747882)
  ADAM12     \[[@r20]\]      AGCTATGTCTTAGAACCAATGAAAAGTG   CCCCGGACGCTTTTCAG               ACCAACAGATACAAACTCTTCCCAGCGAAGA         [NM_003474](http://www.ncbi.nlm.nih.gov/nuccore/194733766) , [NM_021641](http://www.ncbi.nlm.nih.gov/nuccore/194733767)
  ADAM15     \-              CCAGCTGTCACCCTCGAAA            GGCAATCGAGGCAGCAAA              TTCCTCCACTGGCGCAGGGC                    [NM_207191](http://www.ncbi.nlm.nih.gov/nuccore/46909591) , [NM_003815](http://www.ncbi.nlm.nih.gov/nuccore/46909589), [NM_207194](http://www.ncbi.nlm.nih.gov/nuccore/46909593), [NM_207195](http://www.ncbi.nlm.nih.gov/nuccore/46909595), [NM_207196](http://www.ncbi.nlm.nih.gov/nuccore/46909597), [NM_207197](http://www.ncbi.nlm.nih.gov/nuccore/46909599)
  ADAM17     \[[@r19]\]      GAAGTGCCAGGAGGCGATTA           CGGGCACTCACTGCTATTACC           TGCTACTTGCAAAGGCGTGTCCTACTGC            [NM_003183](http://www.ncbi.nlm.nih.gov/nuccore/73747888)
  ADAM19     \-              TGACAGCAAGGGCCAACAC            AGGTCGCTTCTTGGTCTGTTGT          TCGAGCACTCCAAGCCCACCACC                 [NM_023038](http://www.ncbi.nlm.nih.gov/nuccore/NM_023038.3?report=genbank) , [NM_033274](http://www.ncbi.nlm.nih.gov/nuccore/300193021)
  ADAM28     \-              GGGCCCACGATTTGCA               TGAACCTTCCTGTCTTTCAATTTTACT     AGAACATTGCCCTACCTGCCACCAAAC             [NM_014265](http://www.ncbi.nlm.nih.gov/nuccore/98985827) , [NM_021777](http://www.ncbi.nlm.nih.gov/nuccore/98985829)
  ADAMTS1    \[[@r21]\]      GGACAGGTGCAAGCTCATCTG          TCTACAACCTTGGGCTGCAAA           CAAGCCAAAGGCATTGGCTACTTCTTCG            [NM_006988.2](http://www.ncbi.nlm.nih.gov/nuccore/11038653)
  ADAMTS2    \[[@r21]\]      CTGGCAAGCATTGTTTTAAAGGA        GGAGCCAAACGGACTCCAA             ATCTGGCTGACACCTGACATCCTCAAACG           [NM_014244.1](http://www.ncbi.nlm.nih.gov/nuccore/7656866)
  ADAMTS3    \[[@r21]\]      GCAGCATTCCATCGTTACCA           CCATAGAATAATTGATTCCAGGAAGTT     CCATTCCTATGACTGTCTCCTTGATGACCC          [NM_014243.1](http://www.ncbi.nlm.nih.gov/nuccore/21265036)
  ADAMTS4    \[[@r21]\]      CGCTGGATGGGACTGAGTGT           CGCGAACATGACCCAAACTT            CCCGGCAAGTGGTGCTTCAAAGGT                [AF366351.1](http://www.ncbi.nlm.nih.gov/nuccore/18874445)

Assuming 100% efficiency in the RT reactions, either 1 or 5 ng cDNA was used in real-time PCR reactions performed using a real-time PCR machine (ABI7700; Applied Biosystems). Reagent-based assays (TaqMan Universal PCR Master Mix, No AmpErase^®^ UNG; Applied Biosystems) containing all PCR reagents were employed according to the manufacturer's instructions. The amount of amplification associated with priming from genomic DNA contamination was evaluated in control RT reactions that contained all reagents and total RNA sample template without reverse transcriptase. Conditions for the PCR reaction were; 2 min at 50 °C, 10 min at 95 °C and then 40 cycles, each consisting of 15 s at 95 °C and 1 min at 60 °C. The cycle number at which amplification entered the exponential phase (raw data cycle threshold \[C~T~\]) was determined and this number was used as an indicator for the amount of target RNA in each lens tissue sample analyzed. In qualitative raw data analyses the C~T~ value was used to classify gene expression as either very high (C~T~≤20), high (C~T~=21--25), moderate (C~T~=26--30), low (C~T~=31--38), or negligible to undetected (C~T~=39--40). To determine the relative RNA levels in the lens tissue samples, standard curves for each primer/probe set were prepared by using cDNA from one sample and making twofold serial dilutions covering the range equivalent to 20--0.625 ng RNA (for 18S analysis the range was from 1 to 0.03125 ng). Differences in the total amount of RNA present in each sample were normalized to endogenous 18S rRNA gene expression.

Statistical analysis
--------------------

To provide multiple group comparison, statistical analysis was performed using one-way ANOVA with Tukey's post-hoc analysis using p≤0.05 to gauge significance.

Results
=======

*ADAM*/*ADAMTS* gene expression determined by C~T~ analysis in regions of the native human lens
-----------------------------------------------------------------------------------------------

An initial qualitative analysis of the raw data cycle threshold (C~T~) values before 18S rRNA normalization is presented in [Figure 1](#f1){ref-type="fig"}, which shows the relative gene expression ranges for the selected *ADAM*/*ADAMTS* genes detected in three individual native donors at t=0. This is a useful basic analysis to compare the relative expression levels of genes in categories of undetected, low, moderate, high and very high, which we have previously validated extensively \[[@r21],[@r22]\]. Using the C~T~ value as a measure, the majority of the *ADAM*/*ADAMTS* genes analyzed were expressed at the same level in all three lens regions and were classified as undetected or low, except for *ADAMs-9*, *-10*, *-15*, and *-17*. These *ADAM* family members were in all cases classified as highly expressed, except for one donor tissue that expressed moderate levels of *ADAM-15* in lens fibers. Interestingly, expression of *ADAMTS-1* and *-2* was low in the anterior epithelia and fiber cells, but was moderate to high in the equatorial region. *ADAMTS-14* was largely classified as negligible or undetected in the samples tested.

![*ADAM*/*ADAMTS* gene expression profiles were classified in lens regions (donors 1--3). The cycle threshold number (C~T~) was used to classify gene expression as either very high (C~T~≤20), high (C~T~=21--25), moderate (C~T~=26--30), low (C~T~=31--38) or negligible to undetected (C~T~=39--40). Donor information; number: (1--3), sex (F; female, M; male), age and ophthalmic history; 1: F, 74, none; 2: M, 84, none; 3: M, 81, none.](mv-v16-2765-f1){#f1}

*ADAM*/*ADAMTS* gene expression in regions of the native human lens determined using a relative standard curve
--------------------------------------------------------------------------------------------------------------

To provide a measure of the data for the comparison of *ADAM*/*ADAMTS* gene expression between the three lens regions the data were normalized relative to the level of an endogenous control gene, 18S rRNA message, in each sample ([Figure 2](#f2){ref-type="fig"}). There were no statistical differences in gene expression of *ADAM-9*, *-10*, and *-17* genes between the regions examined ([Figure 2A](#f2){ref-type="fig"}). However, regional differences were observed with *ADAM-8* and *-15* and a similar distribution pattern for both was seen ([Figure 2A](#f2){ref-type="fig"}), such that anterior epithelia\>equatorial region\>fibers; a reciprocal pattern was found for *ADAM-19* (i.e., where most expression was detected in the fibers).

![Quantitative comparison of regional *ADAM*/*ADAMTS* gene expression. **A**: *ADAM* and **B**: *ADAMTS* gene expression in each of the three regions of the native human lens; anterior epithelia, equatorial region epithelia and fibers. The x-axis represents the gene of interest/18S expression calculated as mean±SEM. In individual native lens regions significance at p≤0.05 (\*) was determined (ANOVA with Tukey\'s post-hoc analysis) in that region versus the other two regions of each lens.](mv-v16-2765-f2){#f2}

*ADAMTS-1* and *-2* gene expression was highest in the equatorial region, while the anterior epithelia and fibers had low expression of *ADAMTS-1* and *-2* genes ([Figure 2B](#f2){ref-type="fig"}). This pattern of regional expression was significantly different for *ADAMTS-1* only, however it should be noted that of three donors analyzed the pattern was consistent. In the case of *ADAMTS-3* and *-14* there was no significant difference in gene expression across the three regions ([Figure 2B](#f2){ref-type="fig"}).

*ADAM*/*ADAMTS* gene expression determined by C~T~ analysis in the wounded human lens
-------------------------------------------------------------------------------------

In the qualitative analysis of the raw data cycle threshold (C~T~) value, before 18S normalization ([Figure 3](#f3){ref-type="fig"}), *ADAM-12*, *-19*, and *ADAMTS-14* showed a positive shift in gene expression during short-term culture (t=6d) relative to t=0. The expression of *ADAM-12* and *-19* increased from low to moderate and *ADAMTS-14*, which was negligible/undetected before culture, increased to a low expression level. The classification of the remaining *ADAM*/*ADAMTS* genes expressed (*ADAM-8*, *-9*, *-10*, *-15*, *-17*, *-28*, *ADAMTS-1*, *-2*, and *-3*) did not change with short-term culture relative to t=0.

![*ADAM*/*ADAMTS* gene expression in response to mechanical trauma. Gene expression profiles were classified in CBs; at t=0 following in vitro sham cataract operation (left panel), at t=6d, following short-term culture (central panel) and ex vivo after cataract surgery (right panel). The cycle threshold number (C~T~) was used to classify gene expression as either very high (C~T~≤20), high (C~T~=21--25), moderate (C~T~=26--30), low (C~T~=31--38), or negligible to undetected (C~T~=39--40). Donor information; category (t=0, 6d, ex vivo), sex (F; female, M; male), age and ophthalmic history. t=0: F, 74, none; M, 83, none; M, 81, none. t=6d; M, 76, none; F, 76, none; M, 69, no info. Ex vivo; M, 75, bilateral cataract surgery 2001; F, 76, no info; M, 70, no info.](mv-v16-2765-f3){#f3}

In ex vivo capsular bags, the gene expression of all *ADAM*/*ADAMTS* candidates was detectable. The majority of *ADAM*/*ADAMTS* were detected at a low level with the exception of *ADAM-9* and *-10*, which were present at a high level and *ADAM-12*, *-15*, and *-17* were moderately expressed.

Comparison of expression in ex vivo capsular bags to t=0 showed that *ADAM-8*, *-9*, *-10*, *-19*, *-28*, and *ADAMTS-3* remained the same. Several the *ADAM*/*ADAMTS* genes showed an expression differential between ex vivo and t=0 capsular bags; an increase in *ADAM-12* (low elevated to moderate) and *ADAMTS-14* (negligible/undetected elevated to low) and a decrease in *ADAM-15*, *-17* (high reduced to moderate), and *ADAMTS-1* and *-2* (moderate reduced to low) was detected.

*ADAM*/*ADAMTS* gene expression in the wounded human lens determined using a relative standard curve
----------------------------------------------------------------------------------------------------

The quantitative analysis of *ADAM*/*ADAMTS* gene expression, in which data were expressed relative to 18S ribosomal control, is shown in [Figure 4](#f4){ref-type="fig"}. Following surgical trauma, a significant increase in expression of *ADAM-9*, *-15*, and *ADAMTS-3*/*ADAMTS* (*ADAM-9*, *-12*, *-15*, *-19*, *-28*, *ADAMTS-3*, and *-14*) was detected in t=6d capsular bags ([Figure 4A,B](#f4){ref-type="fig"}). While only *ADAM-9*, *-15*, and *ADAMTS-3* at t=6d reached a statistically significant difference from t=0. After short-term culture, the expression of *ADAM-10*, *-12*, *-19*, *-28*, *ADAMTS-2*, and *-14* remained unchanged from t=0 ([Figure 4A,B](#f4){ref-type="fig"}). A significant reduction in the expression was detected for *ADAMTS-1* ([Figure 4B](#f4){ref-type="fig"}).

![Quantitative assessment of *ADAM*/*ADAMTS* gene expression in response to mechanical trauma. **A**: *ADAM* and **B**: *ADAMTS* gene expression analysis in human capsular bags; at t=0 following in vitro sham cataract operation, at t=6d, following short-term culture and ex vivo after cataract surgery. The y-axis represents the gene of interest/18S expression calculated as mean±SEM \* indicates a ignificant difference in gene expression between groups at p≤0.05 determined by ANOVA with Tukey\'s post-hoc analysis.](mv-v16-2765-f4){#f4}

In comparison with t=0 capsular bags, the gene expression of the ex vivo samples was largely unchanged, except for *ADAM-28* and *ADAMTS-14* that increased and *ADAMTS-1* and *-2* that decreased ([Figure 4A,B](#f4){ref-type="fig"}). Notably, *ADAM-9* gene expression was significantly different from t=0 and was reduced by 50.2%. The change in *ADAMTS-1* was the only statistically significant gene expression differential detected.

Discussion
==========

Adamalysin gene expression in native lens regions
-------------------------------------------------

The ADAMs are known to modulate cell-cell and cell-matrix interaction with cell surface adhesion molecules and integrins through various mechanisms including protein ectodomain shedding and the adhesive qualities of the disintegrin and Cys-rich domains. In the mouse lens, the particular importance of integrin adhesion molecules is demonstrated by the dramatic lens microphthalmia that occurs in the adult β1 integrin knock out \[[@r23]\]. Human ADAM-15 in particular contains an RGD integrin-binding motif \[[@r24]\] and others alternatively contain sequences such as ECD or DCD \[[@r2],[@r25]\]. The ADAM-15 RGD motif is involved in adherence to αvβ3 and α5β1 integrins \[[@r26],[@r27]\]. However, ADAM-15 can additionally bind α9β1 integrins in an RGD-independent mechanism \[[@r28]\], which indicates the adhesive potential for ADAMs lacking an RGD motif. Cell contact and adhesion are likely to be functions common to all lens cells and may account for the high and consistent expression of particular ADAM genes such as ADAM-9, −10, −15 and −17 in each of the native human lens regions determined by the present study. ADAM-9 is a potential ligand for α6β1 integrin \[[@r29]\] and the α6 and β1 integrin subunit genes are expressed by the human lens epithelia-derived cell line FHL-124 \[[@r30]\]. Monoclonal antibodies have detected the β1 subunit expressed by lens epithelial cells of capsulorhexis specimens removed at surgery \[[@r31]\] and it is detected at the fiber cell-capsule interface \[[@r32]\]. These observations indicate a potential adhesive role for ADAM-9 in the lens epithelia and during fiber differentiation.

In keeping with the theme of cell contact and adhesion, in non-ocular tissues ADAM-10 is implicated in the normal turnover of cadherin adhesion molecules \[[@r33]\] and in the shedding of cell surface adhesion proteins such as CD44v6 \[[@r10]\]. Both of these examples are mediated by protein ectodomain cleavage and are relevant to the maintenance of native lens compartments. Roles in adhesion via integrin interactions are similarly reported for ADAM-15 and −17 and may be involved in maintaining the quiescence of the native lens epithelia and controlling migration in lens cells. For example, the quantitative data presented in [Figure 2](#f2){ref-type="fig"} show that ADAM-15 was significantly expressed by the quiescent anterior lens epithelia. In airway smooth muscle cells a recombinant ADAM-15 disintegrin domain construct prevented PDGF-induced matrix adhesion and migration through the β1 integrin \[[@r34]\]. Also migration of human lens epithelial cells induced in culture can be prevented with an interacting anti-β1 monoclonal antibody \[[@r31]\]. Therefore, an ADAM-15-β1 integrin interaction may prevent cell migration of the anterior epithelia. Moreover, in support of an inhibitory interaction the integrin binding characteristics of ADAM-15 can prevent platelet aggregation \[[@r35]\].

Consistently high *ADAM-17* gene expression was detected in all native lens regions. In vitro, ADAM-17-mediated adhesion occurs between the disintegrin region (in an RGD peptide-sensitive interaction) and α5β1 integrin localized at focal adhesions in sparsely seeded HeLa cell cultures and cell-cell junctions in confluent cultures \[[@r36]\]. A further in vitro study demonstrated that ADAM-17 inhibits migration through α5β1 integrin but not α4β1 \[[@r37]\]. Taken together, these studies suggest that the expression of differing integrin receptor subtypes target or modulate ADAM activity to support roles in cellular adhesion and migration, and in the lens could play a role in tissue integrity in the samples investigated.

Of the 4 ADAMTS family members studied, ADAMTS-1 and ADAMTS-2 were the most abundant and resided largely in the equatorial region. At the lens equator multiple processes are occurring, including cell division and migration and differentiation. These processes continue to occur throughout life and contribute to the persistent, but linear increase of human lens growth with age \[[@r38]-[@r40]\]. Moreover, injury to the lens, such as a cataract surgery can provoke enhanced levels of cell proliferation and migration \[[@r40],[@r41]\]. This increased activity occurs in all ages, but is greater in the young \[[@r41],[@r42]\]. The promotion of growth responses following injury contribute greatly to posterior capsule opacification and explain why it is a major healthcare problem affecting millions, of largely elderly patients \[[@r4]\]. In other tissues ADAMTS-1 has been associated with migration and proliferation. For example, ADAMTS-1 can be detected in immortalized human corneal fibroblasts \[[@r11]\] and a binding of a co-factor fibulin-1 promotes aggrecan cleavage \[[@r43]\], which can regulate migration \[[@r11]\]. It is therefore feasible that ADAMTS-1 facilitates cell division, migration and differentiation in the lens.

Adamalysin gene expression in the wounded lens
----------------------------------------------

The short-term lens wounding stimulus led to a significant increase in *ADAM-9* and *-15* gene expression. Among the genes that have been associated with the wounding response are the epidermal growth factor receptors (EGFRs). The EGFRs are transactivated by G-protein-coupled-receptors (GPCRs), in a mechanism that involves metalloproteinase-dependent shedding of EGFR ligands, subsequent EGFR activation and the initiation of downstream cell signaling \[[@r44]\]. For example in the dermis, EGFR ligands including heparin binding-EGF (HB-EGF), are proteolytically shed from the cell surface in response to injury and play leading roles in wound healing, including increasing cell migration \[[@r45],[@r46]\]. In the anterior segment, corneal wounding stimulates release of the GPCR agonist lysophosphatidic acid (LPA), which accelerates wound healing i.e., cell migration and wound closure through shedding of HB-EGF and EGFR transactivation \[[@r47]\]. Thus, ADAM-mediated proteolysis plays an important part in releasing proteins from the cell surface to modulate their bioavailability to change cell behavior.

In the lens, there is a lack of research to substantiate the role of the ADAMs in EGFR ligand shedding and this is an area that needs addressing. However, the upregulation of the ADAM proteases has been previously documented in activated cells of other tissues \[[@r48]\]. ADAM-9 is known to shed HB-EGF from the cell surface when the cytoplasmic domain is bound by protein kinase C delta \[[@r49]\]. ADAM-15 is implicated in EGFR ligand shedding, possibly through EGFR transactivation \[[@r50],[@r51]\] and catalyzes the shedding of a soluble E-cadherin fragment that is increased during the progression of breast cancer \[[@r52]\]. EGFR ligands including HB-EGF are expressed by the lens epithelial cell line, FHL 124, which is suggested to better represent a wounded lens cell line (due to the expression of genes usually associated with vigorously growing or wounded lens cells) \[[@r30]\]. Moreover, despite the lack of information regarding ADAM sheddase activity against EGFR ligands in the lens, the role of the EGF/R stimulation pathway in lens cells has been under investigation for some time and the presence of EGF and EGFR is documented in human lens epithelial cells \[[@r53]-[@r56]\]. The EGFR immunolocalizes to both the quiescent anterior and dividing equatorial epithelial cells of the native human lens and EGFR activation by EGF is strongest at the equator \[[@r55]\]. EGFRs are similarly detectable in activated lens epithelial cells that are proliferating and migrating following sham surgical injury and EGFR blockade can decrease the rate of this lens epithelial cell growth \[[@r55]\]. In other studies EGF treatment has been shown to promote the migration of human lens epithelial cells \[[@r57]\]. One can therefore conclude that ADAM-9 and −15, which are elevated following surgery, may potentially be involved in the processes that propagate a wound response in lens cells, which may ultimately lead to the development of PCO secondary to cataract surgery.

The data generated from long-term samples (ex vivo) indicate a reduction in *ADAM-9* gene expression following surgical trauma. Interestingly, a down-regulation in *ADAM-9* gene expression has been associated with human anterior polar cataract or ASC \[[@r43]\]. The α6β1 integrins are suggested to be potential ADAM-9 receptors \[[@r29]\]. β1 integrins are expressed by lens cells \[[@r30]-[@r32]\] and TGF-β1 down-regulates *ADAM-9* and the α6 integrin subunit \[[@r13],[@r58]\], which highlights that a down-regulation of *ADAM-9* could be involved in a loss of cell-cell contact during the pathogenesis of anterior sub-capsular cataract (ASC) and potentially also PCO, as they are phenotypically similar \[[@r59],[@r60]\].

Importantly, ADAM-10 is one of the ADAMs that is highly expressed in the long-term wounding samples. In aberrantly activated lens epithelial cells ADAM-10 is likely to conserve its proteolytic functions for the cell proliferation and migration that is seen in the development of PCO. In other tissues, ADAM-10 is associated with aberrant cadherin processing, which is thought to cause downstream functional alterations in cell-cell adhesion and β-catenin signaling in the pathogenesis of disease states such as cancer and Alzheimer disease \[[@r61],[@r62]\]. The destabilization of cell-cell junctions has also been associated with cataract in induced animal models via TGFβ \[[@r63]\] and stress \[[@r64]\]. TGFβ induced E-cadherin shedding in an ex vivo rat cataract model was attributed to members of the matrix mettalloproteinases \[[@r63]\]. However, ADAM-10 could be equally responsible for E-cadherin shedding and may be involved in the pathogenesis of ASC and PCO.

Of the ADAMTS family members only ADAMTS-1 expression was significantly changed following injury; however ADAMTS-2 showed a similar pattern. Following injury, expression was dramatically reduced; suggesting ADAMTS-1 is not directly driving a wound-healing response. Wound-healing responses are associated with enhanced migration and division and this is typical of events following cataract surgery \[[@r4]\]. Interestingly, it has been observed that hormonally stimulated osteoblasts upregulate *ADAMTS-1* expression on collagen coated dishes, which is associated with reduced migration \[[@r65]\]. Therefore, if *ADAMTS-1* expression suppresses migration then the observed reduction in lens cells following injury is likely to promote migration. This concept is supported by other studies, which report that low concentrations of ADAMTS-1 were seen to stimulate fibroblast migration in healing skin wounds, whereas high concentrations inhibited migration through sequestration of fibroblast growth factor \[[@r66]\].

In conclusion, we have provided a robust analysis of *ADAM*/*ADAMTS* gene expression in the normal and wounded human lens and have described their potential functional implications. An important unexplored theme is the ability of TGFβ to regulate *ADAM*/*ADAMTS* expression because this may modulate cellular adhesion for roles in the migration and proliferation of transdifferentiated lens cells; lens epithelial cell transdifferentiation is promoted by TGFβ and involved in PCO development \[[@r4],[@r67]\]. The relationship between, ADAM/ADAMTS, TGFβ, and PCO therefore warrants further investigation in the future.
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